NanoVation Therapeutics™ (NTx) is pleased to announce the expansion of its global gene therapy builder with the launch of its first GENErator™, NanoVationTx™ UK. The operations of NTx UK will… Read More
The Canadian Society for Immunology (CSI) has awarded Dr. Brad Nelson, distinguished scientist and co-director of BC Cancer’s Immunotherapy Program, with the prestigious 2022 Hardy Cinader Award. This award is… Read More
First Phase 3 Study To Demonstrate Statistically Significant Improvement in DFS in the Adjuvant Setting for Patients With Stage IB-IIIA NSCLC Regardless of PD-L1 Expression KENILWORTH, N.J.– Merck (NYSE: MRK),… Read More
These investments will help respond to the toxic illegal drug supply and prevent overdose in Ontario and British Columbia TORONTO — The evidence is clear that the COVID-19 pandemic has… Read More
UBC concussion study could pave the way for safer hockey A high-tech mouthguard worn by UBC Thunderbird hockey players will record every big hit of the upcoming playoffs to capture… Read More
